Kit ELISA uPAR sandwich (PLAUR) (human): quantitative determination of Hu uPAR in serum, plasma or cell culture medium. The test recognizes only the natural and recombinant forms of Hu uPAR.
Kit ELISA uPAR sandwich (PLAUR) (human): quantitative determination of Hu uPAR in serum, plasma or cell culture medium. The test recognizes only the natural and recombinant forms of Hu uPAR.
Method principle: This ELISA solid phase sandwich test (immuno-enzymatic dose) measures the amount of target bound between a pair of matched antibodies. A specific target antibody is pre-adsorbed into the wells of the supplied microplate. Samples, standards or controls are added to these wells and bind to immobilized antibodies (capture antibodies). The sandwich is formed by adding the second antibody (detection antibody), then a substrate solution reacts with the enzyme-antibodies-target complex to produce a measurable signal. The intensity of this signal is directly proportional to the concentration of the target present in the original sample.
Rigorous validation: Each batch manufactured from this ELISA kit is checked for criteria such as sensitivity, specificity, accuracy and reproducibility from one batch to another (see the package leaflet for more information on validation).
The urokinase-type plasminogen activator receptor is a key molecule in regulating the activation of cell surface plasminogen and plays an important role in many normal and pathological processes. Human code 335 amino acids, including a signal peptide of 22 predicted residues and a portion at C hydrophobic termination. It produces a highly glycosylated protein of about 50 kD in monocytes where it is anchored to the plasma membrane by glycosyl-phosphatidylinositol bond. PLAUR, also known as d的UPAR, is directly associated with the SELL carbohydrate binding domain in the neutrophil membrane, an association similar to that between PLAUR and beta-2 integrins. Calcium mobilization at PLAUR is dependent on SELL. The levels of d-mRNA UPAR are correlated with the invasive potential of l-endome carcinomas and show an x 33 increase in the levels of d-mRNA UPAR in endometrial tumours of advanced clinical stage compared to normal endometrial tissues. In addition, the increase in mRNA levels of UPAR is linearly correlated with the progression of the disease stage. The protein expression of the UPAR is positively correlated with the rate of recurrence and mortality in patients with l'endometrial cancer. The UPAR appears to be a useful prognostic marker for advanced l-endometrial cancer.
Sensitivity
Sensitivity of dosage: 15 pg/ml.
Measurement range
Dose range: 16.38 pg/ml to 4.000 pg/ml.
Duration of dosing
Total dosage duration: 4 hours 45 min.
Samples
Sample type: Plasma, Serum, Surnatant (plasma volume, 50 μl; serum, 50 μl; supernatant, 100 μl).
Technical specifications
| General |
| Brand | Invitrogen |
| Supplier ref. (Fisher Scientific) | 17105549 |
| Specifications |
| Accession number | Q03405 |
| Dose range | 16.38 pg/ml to 4.000 pg/ml |
| Sensitivity of the dosage | 15 pg/ml |
| Calibration range | 15 pg/ml to 4.000 pg/ml |
| Dose | ELISA solid-phase sandwich |
| Conjugate | Biotin |
| Product type | Kit ELISA |
| Protein family | Proteases, peptidases & inhibitors |
| Type of sample | Plasma, Serum, Surnatant |
| Specificity | This ELISA kit shows no cross-reactivity with the following tested cytokines: human angiogenin, BDNF, BLC, CNTF, ENA-78, FGF-4, IL-1 alpha, IL-1 beta, IL-2, IL-3, IL-4, IL-5, IL-6, IL-7, IL-8, IL-9, IL-11, IL-12 p70, IL-12 p40, IL-13, IL-15, IL-309, IP-10, FGF-4, FGF-6, FGF-7, G-CSF, GD |
| Sufficient for | 5 x 96 dosages |
| Target species | Human |
| For use with (application) | ELISA, protein dosage, protein biology, cancerology, immunology, neuroscience, neurobiology, protein detection, protein analyses |
| For use with (equipment) | Colorimetric microplate reader |
| Genetic identification (Enter) | 5329 |
| Gene symbol(s) | CD87,U-PAR,UPAR,URKR |
| Coefficient of inter-dose variation | <12% |
| Coefficient of intra-dose variation | <10% |
| Contents of kits | 96-well pre-coated plates, SAV-HRP, Chromogen, Stop solution, Adhesive plate covers, Wash pad, Stalcon, Dose diluent concentrate, Biotinylated detection antibody |
| Marker or dye | HRP |
| Quantity | 5 x 96 tests |
| Regulatory status | RUO |
| Research disciplines | Inflammation |
| Synonym | CD87, U-PAR, UPAR, Urkr |
| Target | Human |
| Test time | 1 hour 20 minutes. |
| Physical characteristics |
| Volume of sample | Plasma, 50 μl; serum, 50 μl; supernatant, 100 μl |
| Storage and shipping |
| Storage conditions | 2°C to 8°C |
| Total duration of dosing | 4:45 a.m. |
Origin and customs
| Manufacturer ref. | EHPLAURX5 |
|---|
| Country of origin | United States |
|---|
A question or a specific configuration?
Contact us for a quote.